Gelder Mark S. MD 4
4 · Onconova Therapeutics, Inc. · Filed Jun 17, 2021
Insider Transaction Report
Form 4
Gelder Mark S. MD
Chief Medical Officer
Transactions
- Award
Stock Option (right to purchase)
2021-06-14+20,000→ 20,000 totalExercise: $7.56Exp: 2031-06-14→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Theses options vest over 4 years, 25% on the first anniversary of the grant and thereafter in 36 equal monthly installments over the next 3 years.